Add to ORKGKey words Angioplasty, transluminal, percutaneous coronary; stents/ economics; National Health System (BR); pharmacologics stents
We investigated the clinical and economic impact of sirolimus-eluting coronary stents (SES) at a nat...
We compared one-year clinical outcomes of different drug eluting stents (DES) used in a prospective ...
Background: Drug-eluting stents (DES) represent a major advance in the management of ischemic heart ...
Objectives: To compare the cost-effectiveness ratios of sirolimus-eluting stents (SES) with bare-met...
Cardiovascular diseases are the main cause of a morbidity and mortality in Brazil. They have a signi...
© 2020 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U. This is an open acc...
The initial treatment options for patients with stable coronary artery disease include optimal medic...
At present, 90 to 95 percent of percutaneous coronary interventions involve the implantation of a st...
Background: Latin America has witnessed a marked increase in cardiovascular (CV) disease, the leadin...
compare the clinical results of the best technology of percutaneous coronary interventions (PCI) usi...
taneous transluminal coronary angioplasty (PTCA) with epidemiological and economic implications. Met...
Angioplasty, stents, restenosis, coronary artery bypass surgery. The authors review percutaneous cor...
O levantamento do número de medicamentos inovadores licenciados no Brasil pela agência reguladora de...
FUNDAMENTO: Stents farmacológicos representam opção adicional para o tratamento da doença arterial c...
Objetivos: Comparar as relações de custo-efetividade do stent recoberto (SR) por rapamicina com o st...
We investigated the clinical and economic impact of sirolimus-eluting coronary stents (SES) at a nat...
We compared one-year clinical outcomes of different drug eluting stents (DES) used in a prospective ...
Background: Drug-eluting stents (DES) represent a major advance in the management of ischemic heart ...
Objectives: To compare the cost-effectiveness ratios of sirolimus-eluting stents (SES) with bare-met...
Cardiovascular diseases are the main cause of a morbidity and mortality in Brazil. They have a signi...
© 2020 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U. This is an open acc...
The initial treatment options for patients with stable coronary artery disease include optimal medic...
At present, 90 to 95 percent of percutaneous coronary interventions involve the implantation of a st...
Background: Latin America has witnessed a marked increase in cardiovascular (CV) disease, the leadin...
compare the clinical results of the best technology of percutaneous coronary interventions (PCI) usi...
taneous transluminal coronary angioplasty (PTCA) with epidemiological and economic implications. Met...
Angioplasty, stents, restenosis, coronary artery bypass surgery. The authors review percutaneous cor...
O levantamento do número de medicamentos inovadores licenciados no Brasil pela agência reguladora de...
FUNDAMENTO: Stents farmacológicos representam opção adicional para o tratamento da doença arterial c...
Objetivos: Comparar as relações de custo-efetividade do stent recoberto (SR) por rapamicina com o st...
We investigated the clinical and economic impact of sirolimus-eluting coronary stents (SES) at a nat...
We compared one-year clinical outcomes of different drug eluting stents (DES) used in a prospective ...
Background: Drug-eluting stents (DES) represent a major advance in the management of ischemic heart ...